The UK HSE review associates occupational asthma with piperazine use, particularly flaking dusty anhydrous piperazine, reports asthma symptoms among exposed workers, and classifies piperazine as a respiratory sensitiser under its reviewed criteria.
Source: pdf ↗ · saved source
page 71 · C23: PIPERAZINE — Summary and conclusion · 1
page 71 · C23: PIPERAZINE — Summary and conclusion · 1
The use of piperazine has been associated with the development of asthma in the workplace, and some limited positive bronchial challenge data are available. The finding that specific immunoglobulin E (IgE) has been found in about half of those with symptoms, but rarely occurs in exposed, asymptomatic individuals, suggests an immunological basis for the asthma.